BioWorld MedTech

April 15, 2014

Medtronic faces debilitating U.S. injunction on CoreValve sales

Edwards Lifesciences (Irvine, California) has won an important battle in a six-year patent war with Medtronic (Minneapolis) over Medtronic's CoreValve transcatheter aortic valve replacement (TAVR/TAVI) system. Read More

Financings Roundup: Sant Ventures boosts size of most recent fund to $139 million

Final data from PRECISE trial to bepublished in American Heart Journal

Washington Roundup: Importers beware; Health Canada report cites SOPs for distribution

International report: Chiyoda Technol to distribute Mevion's S250 in Japan

Agreements/contracts: SBG Technology Solutions awarded VA contract extension for VistA

Deals roundup: Chindex receives M&A cash bid from buyer consortium

HIT Roundup: Osler to use Medworxx patient flow platform

Syneron gets clearance for UltraShape system

Product briefs

Briefly Noted

People in Places

MDD's Cardio Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...